ABL allosteric inhibitors synergize with statins to enhance apoptosis of metastatic lung cancer cells
Jillian Hattaway Luttman(Duke University), Ann Marie Pendergast(Duke University), Jiaxing Lin(Duke University), Amanda Nichols(Duke University), Clay Rouse(Duke University), Kevin Lin(The University of Texas MD Anderson Cancer Center), Jacob P. Hoj(Duke University), Nancie J. MacIver(University of North Carolina at Chapel Hill), Jing Gu(Dalian Ocean University), Kris C. Wood(Duke University)
Cited by 1
Related Papers
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation
|Journal of Clinical Investigation|2014|717
Changes in Nutritional Status Impact Immune Cell Metabolism and Function
|Frontiers in Immunology|2018|515